HIV Vaccine Trial In Africa Halts Early After Preliminary Data Suggest It Would Be Ineffective

Reuters (12/7, Biryabarema, Rigby) reports, “A trial of an experimental HIV vaccine in Uganda, Tanzania and South Africa has been stopped early after preliminary data suggested it would not be effective in preventing infection, according to the trial’s chief investigator.” The trial, which “was testing two different combinations of experimental HIV vaccines,” began in December 2020 and was due to end in 2024.